エイコサペンタエン酸市場：供給源、形態、用途別-2025～2030年の世界予測

エイコサペンタエン酸市場は、2023年に8億6,250万米ドルと評価され、2024年には9億494万米ドルに達すると予測され、CAGR 5.16％で成長し、2030年には12億2,744万米ドルに達すると予測されています。

エイコサペンタエン酸（EPA）は、主に魚油に含まれるオメガ3系脂肪酸であり、抗炎症作用や心血管サポートなど、その重要な健康効果が認められています。オメガ3系脂肪酸の健康効果に対する意識の高まりから、栄養補助食品、機能性食品、医薬品、栄養補助食品などにおいて、EPAの必要性と用途がますます顕著になっています。EPAの最終用途は医療、飲食品、化粧品などさまざまなセグメントに広がっており、治療効果やスキンケア、アンチエイジング製剤における役割も活用されています。EPA市場は、消費者の健康意識の高まり、慢性疾患の有病率の増加、オメガ3系摂取を推進する政府の健康施策による強力な支援といった要因によって活性化されています。市場に存在する最新のビジネス機会としては、植物由来のサプリメントにおけるEPA用途の拡大、菜食主義者やベジタリアンの消費者層の増加への対応、さまざまな製品製剤におけるEPAの安定性と送達性を高めるマイクロカプセル化技術の革新などが挙げられます。しかし同市場は、高い生産コストや乱獲に関連する持続可能性の課題といった限界に直面しています。EPA抽出のための藻類培養のような代替資源に投資することで、こうした課題に効果的に対処する企業は、このセグメントのイノベーションを主導することができると考えられます。規制環境も課題となっており、地域によって基準が異なるため、世界市場への浸透が複雑になっています。技術革新の最良のセグメントとしては、より効率的でサステイナブル抽出方法の開発や、個別化栄養ソリューションにおけるEPA使用の最適化などが挙げられます。市場競争は依然として激しく、競合を維持するためには継続的な製品革新と戦略的提携が必要であり、持続的な事業成長のためには機敏さと先見性のある戦略が求められるダイナミックな市場であることを示唆しています。

市場力学：急速に進化するエイコサペンタエン酸市場の主要市場洞察を公開

エイコサペンタエン酸市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率上昇リスクを低下させるEPAの重要性
  • 栄養食品と乳幼児向け食品への支出の増加
• 市場抑制要因
  • EPAに必要な原料の入手性に関する問題
• 市場機会
  • サステイナブル菜食主義者向けEPAの採用
  • EPA製品拡大のための投資増加
• 市場課題
  • EPAの摂取に伴う副作用の可能性

ポーターのファイブフォース：エイコサペンタエン酸市場をナビゲートする戦略ツール

ポーターのファイブフォース：」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：エイコサペンタエン酸市場における外部からの影響の把握

外部マクロ環境要因は、エイコサペンタエン酸市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：エイコサペンタエン酸市場における競合情勢の把握

エイコサペンタエン酸市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：エイコサペンタエン酸市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、エイコサペンタエン酸市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：エイコサペンタエン酸市場における成功への道筋を描く

エイコサペンタエン酸市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延リスクを低下させるEPAの重要性
    • 栄養食品と乳児用食品への支出の増加
  • 抑制要因
    • EPAに必要な原料の入手性に関する問題
  • 機会
    • サステイナブルヴィーガンEPAの採用
    • EPAの提供拡大に向けた投資増加
  • 課題
    • EPA摂取に伴う副作用の可能性
• 市場セグメンテーション分析
  • 供給源：サステイナブル代替品を提供し、植物ベースの食事の現在の動向を満たす藻類油の使用が増えている
  • 用途：機能性飲食品におけるエイコサペンタエン酸の潜在的可能性が高まり、健康上の利点がさらに高まる
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 エイコサペンタエン酸市場：供給源別

• イントロダクション
• 藻類
• 魚
• オキアミ

第7章 エイコサペンタエン酸市場：形態別

• イントロダクション
• エチルエステル
• トリグリセリド

第8章 エイコサペンタエン酸市場：用途別

• イントロダクション
• 栄養補助食品
• 機能性飲食品
• 医薬品

第9章 南北アメリカのエイコサペンタエン酸市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のエイコサペンタエン酸市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのエイコサペンタエン酸市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Amneal、イコサペントエチル酸ソフトジェルカプセルの追加でポートフォリオを拡大
  • Biomar、オメガ3カメリナの商品化に向けて提携
  • AmarinとNeopharm、イスラエルにおけるヴァズケパ（イコサペントエチル）の独占販売契約を発表
• 戦略分析と提言

企業一覧

• AlgiSys BioSciences Inc.
• Archer Daniels Midland Company
• Arctic Nutrition AG
• Asterisk Laboratories（I）Pvt. Ltd.
• BASF SE
• BIOSEARCH, SA
• Cayman Chemical Company
• Corbion N.V.
• Croda International PLC
• Epax Norway AS
• Evonik Industries AG
• Golden Omega S.A.
• Indo Rama Engineers
• KD Pharma Group
• Koninklijke DSM N.V.
• Novasep Holding SAS
• Novotech Nutraceuticals, Inc.
• Omega Protein Corporation
• Orkla Health AS
• Pelagia AS
• Santa Cruz BIoTechnology, Inc.
• Shandong Yuwang Pharmaceutical Co., Ltd.
• SimSon Pharma Limited
• Sinomega BIoTech Engineering Co.,Ltd.
• Toronto Research Chemicals Inc.

LIST OF FIGURES

• FIGURE 1. EICOSAPENTAENOIC ACID MARKET RESEARCH PROCESS
• FIGURE 2. EICOSAPENTAENOIC ACID MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EICOSAPENTAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. EICOSAPENTAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EICOSAPENTAENOIC ACID MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EICOSAPENTAENOIC ACID MARKET DYNAMICS
• TABLE 7. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY KRILL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY ETHYL ESTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 30. CANADA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 47. CHINA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 50. INDIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 102. ITALY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 114. POLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 117. QATAR EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM EICOSAPENTAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. EICOSAPENTAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. EICOSAPENTAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

The Eicosapentaenoic Acid Market was valued at USD 862.50 million in 2023, expected to reach USD 904.94 million in 2024, and is projected to grow at a CAGR of 5.16%, to USD 1,227.44 million by 2030.

Eicosapentaenoic Acid (EPA) is an omega-3 fatty acid primarily found in fish oils and is recognized for its significant health benefits, including anti-inflammatory properties and cardiovascular support. The necessity and application of EPA are increasingly pronounced in nutraceuticals, functional foods, pharmaceuticals, and dietary supplements due to rising awareness of omega-3's health benefits. The end-use scope of EPA spans across various sectors including healthcare, food and beverage, and cosmetics, as it is leveraged for its therapeutic properties as well as its role in skincare and anti-aging formulations. The market for EPA is fueled by factors such as growing consumer health consciousness, the increasing prevalence of chronic diseases, and strong support from governmental health initiatives promoting omega-3 intake. Latest opportunities present in the market include the expansion of EPA applications in plant-based supplements, addressing the growing vegan and vegetarian consumer base, and the innovation of microencapsulation technologies, which enhance the stability and delivery of EPA in various product formulations. However, the market faces limitations such as high production costs and sustainability challenges related to overfishing-a key factor posing both ecological and economic hurdles. Companies that effectively address these challenges, perhaps by investing in alternative sources like algae cultivation for EPA extraction, can lead innovation in the field. The regulatory environment also serves as a challenging factor, with varying regional standards that complicate global market penetration. Best areas of innovation include developing more efficient and sustainable extraction methods and optimizing EPA use in personalized nutrition solutions. The market remains highly competitive, necessitating continuous product innovation and strategic partnerships to maintain a competitive edge, suggesting a dynamic landscape that requires agility and forward-thinking strategies for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Eicosapentaenoic Acid Market

The Eicosapentaenoic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significance of EPA for lowering risk of rising prevalence of chronic diseases
  • Rise in spending on nutritional and infant food products
• Market Restraints
  • Issues associated with availability of raw materials required for EPA
• Market Opportunities
  • Introduction of sustainable and vegan EPA
  • Rising investments to expand EPA offerings
• Market Challenges
  • Possibilities of side effects associated with consumption of EPA

Porter's Five Forces: A Strategic Tool for Navigating the Eicosapentaenoic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Eicosapentaenoic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Eicosapentaenoic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Eicosapentaenoic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Eicosapentaenoic Acid Market

A detailed market share analysis in the Eicosapentaenoic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Eicosapentaenoic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Eicosapentaenoic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Eicosapentaenoic Acid Market

A strategic analysis of the Eicosapentaenoic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Eicosapentaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include AlgiSys BioSciences Inc., Archer Daniels Midland Company, Arctic Nutrition AG, Asterisk Laboratories (I) Pvt. Ltd., BASF SE, BIOSEARCH, SA, Cayman Chemical Company, Corbion N.V., Croda International PLC, Epax Norway AS, Evonik Industries AG, Golden Omega S.A., Indo Rama Engineers, KD Pharma Group, Koninklijke DSM N.V., Novasep Holding SAS, Novotech Nutraceuticals, Inc., Omega Protein Corporation, Orkla Health AS, Pelagia AS, Santa Cruz Biotechnology, Inc., Shandong Yuwang Pharmaceutical Co., Ltd., SimSon Pharma Limited, Sinomega Biotech Engineering Co.,Ltd., and Toronto Research Chemicals Inc..

Market Segmentation & Coverage

This research report categorizes the Eicosapentaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Source, market is studied across Algae, Fish, and Krill.
• Based on Form, market is studied across Ethyl Esters and Triglycerides.
• Based on Application, market is studied across Dietary Supplements, Functional Food & Beverages, and Pharmaceuticals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significance of EPA for lowering risk of rising prevalence of chronic diseases
    • 5.1.1.2. Rise in spending on nutritional and infant food products
  • 5.1.2. Restraints
    • 5.1.2.1. Issues associated with availability of raw materials required for EPA
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of sustainable and vegan EPA
    • 5.1.3.2. Rising investments to expand EPA offerings
  • 5.1.4. Challenges
    • 5.1.4.1. Possibilities of side effects associated with consumption of EPA
• 5.2. Market Segmentation Analysis
  • 5.2.1. Source: Growing usage of algal oil that provides a sustainable alternative and meets the ongoing trend of plant-based diets
  • 5.2.2. Application: Rising potential of eicosapentaenoic acid in functional food & beverages to provide added health benefits
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Eicosapentaenoic Acid Market, by Source

• 6.1. Introduction
• 6.2. Algae
• 6.3. Fish
• 6.4. Krill

7. Eicosapentaenoic Acid Market, by Form

• 7.1. Introduction
• 7.2. Ethyl Esters
• 7.3. Triglycerides

8. Eicosapentaenoic Acid Market, by Application

• 8.1. Introduction
• 8.2. Dietary Supplements
• 8.3. Functional Food & Beverages
• 8.4. Pharmaceuticals

9. Americas Eicosapentaenoic Acid Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Eicosapentaenoic Acid Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Eicosapentaenoic Acid Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
  • 12.3.2. Biomar Forms Partnership to Commercialise Omega-3 Camelina
  • 12.3.3. Amarin and Neopharm Announce Exclusive Commercialization Agreement for Vazkepa (Icosapent Ethyl) in Israel
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AlgiSys BioSciences Inc.
• 2. Archer Daniels Midland Company
• 3. Arctic Nutrition AG
• 4. Asterisk Laboratories (I) Pvt. Ltd.
• 5. BASF SE
• 6. BIOSEARCH, SA
• 7. Cayman Chemical Company
• 8. Corbion N.V.
• 9. Croda International PLC
• 10. Epax Norway AS
• 11. Evonik Industries AG
• 12. Golden Omega S.A.
• 13. Indo Rama Engineers
• 14. KD Pharma Group
• 15. Koninklijke DSM N.V.
• 16. Novasep Holding SAS
• 17. Novotech Nutraceuticals, Inc.
• 18. Omega Protein Corporation
• 19. Orkla Health AS
• 20. Pelagia AS
• 21. Santa Cruz Biotechnology, Inc.
• 22. Shandong Yuwang Pharmaceutical Co., Ltd.
• 23. SimSon Pharma Limited
• 24. Sinomega Biotech Engineering Co.,Ltd.
• 25. Toronto Research Chemicals Inc.